Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (2341)	2/12/1998 4:28:00 PM
From: mc	Read Replies (1) \| Respond to of 7041

Please use the private messages for this garbage. It doesn't relate to ZONA. I would rather hear Wexler's ad nauseum repetition than this; at least it's on topic. Now, on to ZONA: We're getting close to the projected date of PFE's anticpated approval to market Viagra. Am I wrong to think that it is the consensus of the bulls on this thread that an NDA is forthcoming from Zonagen prior to Viagra approval so that Vasomax could also potentially get expedited review by the FDA? Also, the closer we get the lower the chance that this will happen. What happens to Zonagen if that happens. I haven't heard any convincing arguments that Vasomax will gain market share based on better efficacy. There has also been some speculation the Vasomax might be priced lower than Viagra but no one is sure about that. Given all of that, is ZONA a time-bomb that'll implode with the approval of Viagra? Good luck, Gary